Pharmaceutical Products

This page lists 17 references in the Main Healthy Skepticism Library relevant to production of pharmaceuticals and medical devices.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL4251
Longstaff C, Thelwell C, Whitton C.
The poor quality of streptokinase products in use in developing countries.
J Thromb Haemost 2005 May 01;3(5):1092-3
Link to source with long URL

HSL853
Carlisle W.
What Went Wrong with Vioxx?
Radio National (Australian Broadcasting Commission) 2005 Apr 10
http://www.abc.net.au/rn/talks/bbing/stories/s1343699.htm

HSL5685
Manchester A.
Counterfeit medicines kill.
Nurs N Z 2005 Apr 01;11(3):10

HSL6576
Menighan TE.
Systems-based approach to risk management.
J Am Pharm Assoc (Wash DC) 2005 Mar-Apr 01;45(2):116

HSL253
Tanne JH.
US consumer group names
BMJ 2004 Apr 24;328(7446):975
http://bmj.bmjjournals.com/cgi/content/full/328/7446/975-c

HSL258
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10;328(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879

HSL267
Slutsky AS, Lavery JV.
Data safety and monitoring boards.
N Engl J Med 2004 Mar 11;350(11):1143-7
http://content.nejm.org/cgi/content/full/350/11/1143

HSL283
McPherson K, Hemminki E.
Synthesising licensing data to assess drug safety.
BMJ 2004 Feb 28;328(7438):518-20
http://bmj.bmjjournals.com/cgi/content/full/328/7438/518

HSL276
Garland EJ.
Facing the evidence: antidepressant treatment in children and adolescents.
CMAJ 2004 Feb 17;170(4):489-91
http://www.cmaj.ca/cgi/content/full/170/4/489

HSL298
Moynihan R.
FDA advisory panel calls for suicide warnings over new antidepressants.
BMJ 2004 Feb 7;328(7435):303
http://bmj.bmjjournals.com/cgi/content/full/328/7435/303-a

HSL303
Lee TH.
N Engl J Med 2004 Jan 15;350(3):211-2
http://content.nejm.org/cgi/content/full/350/3/211

HSL489
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb;73(1):10-6
Link to source with long URL

HSL490
Mansfield P, Henry D, Tonkin A.
Single-enantiomer drugs: elegant science, disappointing effects.
Clin Pharmacokinet 2004;43(5):287-90
Link to source with long URL

HSL350
Freemantle N, Anderson IM, Young P.
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
Br J Psychiatry 2000 Oct;177:292-302
http://bjp.rcpsych.org/cgi/content/full/177/4/292

HSL2450
Hemminki E, McPherson K.
Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease.
Lancet 2000 Feb 12;355(9203):566-9
http://linkinghub.elsevier.com/retrieve/pii/S0140673699034327

HSL8519
Letendre W, Jackson R.
Marketing your prescription compounding practice. Part 3
International Journal of Pharmaceutical Compounding 2000;4(3):199-202

HSL2449
Hemminki E, McPherson K.
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.
BMJ 1997 Jul 19;315(7101):149-53
http://bmj.bmjjournals.com/cgi/content/full/315/7101/149